First-in-human clinical trial of genetically engineered B cells: Application to the treatment of mucopolysaccharidosis type I
SAN FRANCISCO, May 6, 2025 (Globe Newswire) — Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that Scott McIvor, Chief Development Officer at Immusoft, will present recent clinical data in a poster presentation at the American Society of Cell…
